Like pls_老虎社区_美港股上老虎

2021-09-24

Like pls

These 2 Nasdaq Small Caps Just Got Big Boosts<blockquote>这两只纳斯达克小盘股刚刚获得大幅提振</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":861174576,"tweetId":"861174576","gmtCreate":1632476753295,"gmtModify":1632720097895,"author":{"id":3558581504257803,"idStr":"3558581504257803","authorId":3558581504257803,"authorIdStr":"3558581504257803","name":"Kelvinyoon26","avatar":"https://static.tigerbbs.com/17c18f026fcaa77f437cb20f39e1b4ef","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":57,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body>Like pls</body></html>","htmlText":"<html><head></head><body>Like pls</body></html>","text":"Like pls","highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/861174576","repostId":1141045048,"repostType":4,"repost":{"id":"1141045048","kind":"news","pubTimestamp":1632476632,"share":"https://www.laohunote.com/m/news/1141045048?lang=zh_CN&edition=full","pubTime":"2021-09-24 17:43","market":"us","language":"en","title":"These 2 Nasdaq Small Caps Just Got Big Boosts<blockquote>这两只纳斯达克小盘股刚刚获得大幅提振</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1141045048","media":"Motley Fool","summary":"In a rising market, these companies looked especially impressive.\n\nKey Points\n\nThe Nasdaq made big g","content":" In a rising market, these companies looked especially impressive. Key Points<blockquote>在不断上涨的市场中，这些公司看起来尤其令人印象深刻。要点</blockquote> <ul> <li>The Nasdaq made big gains on Thursday.</li> <li>Veritone rose on an extended agreement with CBS News.</li> <li>PAVmed announced it had filed IPO paperwork for a major subsidiary.</li> </ul> Thursday was another great day for the stock market, although the&nbsp;Nasdaq Composite&nbsp;lagged behind some other major market benchmarks. Nevertheless, the Nasdaq managed to gain almost a full percentage point by 12:30 p.m. EDT, and it moved to within just a few percent of all-time record highs.<blockquote><ul><li>纳斯达克周四大幅上涨。</li><li>Veritone 因与 CBS 新闻的延长协议而上涨。</li><li>PAVmed 宣布已为一家主要子公司提交了 IPO 文件。</li></ul>周四对于股市来说又是一个伟大的一天，尽管纳斯达克复合材料落后于其他一些主要市场基准。尽管如此，到美国东部时间中午 12:30，纳斯达克还是成功上涨了几乎整整一个百分点，距离历史高点仅相差几个百分点。</blockquote> Small-cap stocksdon't always get as much attention as their larger counterparts, but they often have the best growth prospects. On Thursday morning, shares of&nbsp;<a href=\"https://laohu8.com/S/VERI\">Veritone Inc.</a> and&nbsp;<a href=\"https://laohu8.com/S/PAVM\">PAVmed</a> were among the top performers on the Nasdaq. Below, we'll look more closely at the news that moved these stocks, with an eye toward trying to figure out whether they'll be able to sustain their upward momentum.<blockquote>小盘股并不总是像大盘股那样受到关注，但它们通常具有最好的增长前景。周四上午，股价<a href=\"https://laohu8.com/S/VERI\">维里通公司。</a>和<a href=\"https://laohu8.com/S/PAVM\">帕夫梅德</a>是纳斯达克上表现最好的演员之一。下面，我们将更仔细地研究推动这些股票走势的消息，着眼于试图弄清楚它们是否能够维持上涨势头。</blockquote> A very valuable agreement for Veritone<blockquote>对于 Veritone 来说，这是一份非常有价值的协议</blockquote> Shares of Veritone were higher by more than 13% on Thursday morning. The provider of enterprise artificial-intelligence software announced a major deal that could play a key role in driving growth in the years to come.<blockquote>周四上午，Veritone 股价上涨超过 13%。这家企业人工智能软件提供商宣布了一项重大交易，该交易可能在未来几年推动增长方面发挥关键作用。</blockquote> Veritone has had a long relationship with the CBS News unit ofViacomCBS(NASDAQ:VIAC), spanning 11 years. It helps television producers, filmmakers, and other content creators take full advantage of news archive footage by using search and discovery functionality in its aiWARE platform. However, with the extended agreement announced today, Veritone and CBS News will boost access to the global creative community, allowing access not just to archival footage but also to breaking news content.<blockquote>Veritone 与 CBS 新闻部门有着长期的合作关系。维亚康姆哥伦比亚广播公司（纳斯达克股票代码：VIAC），跨越 11 年。它通过使用其aiWARE平台中的搜索和发现功能，帮助电视制片人、电影制作人和其他内容创作者充分利用新闻档案镜头。然而，随着今天宣布的扩展协议，Veritone和CBS News将增加对全球创意社区的访问，不仅允许访问档案镜头，还允许访问突发新闻内容。</blockquote> The exclusive international agreement will cover the next three years. With millions of hours in its library of content, CBS News and Veritone see the deal having a substantial influence on creators seeking to tie their content to current and past news events.<blockquote>独家国际协议将涵盖未来三年。CBS News和Veritone拥有数百万小时的内容，他们认为这笔交易将对寻求将内容与当前和过去的新闻事件联系起来的创作者产生重大影响。</blockquote> Veritone has made numerous effortsto foster its growth, including recent acquisitions to expand the functionality of its platform. Those efforts are now paying off in the CBS deal, and it'll be interesting to see how Veritone takes advantage of greater visibility as a result.<blockquote>Veritone 做出了许多努力来促进其发展，包括最近的收购以扩展其平台的功能。这些努力现在在哥伦比亚广播公司的交易中得到了回报，看看Veritone如何利用更大的知名度将会很有趣。</blockquote> Paving the way<blockquote>铺路</blockquote> Elsewhere, shares of PAVmed soared 16%. The maker of medical devices plans to do an initial public offering for one of its subsidiaries, potentially offering shareholders a chance to benefit directly from its prospects.<blockquote>其他方面，PAVmed 股价飙升 16%。这家医疗器械制造商计划为其子公司之一进行首次公开募股，这可能为股东提供直接从其前景中受益的机会。</blockquote> PAVmed is a majority owner of Lucid Diagnostics, which is responsible for what it says is the first and only commercial tools for widespread early detection of esophageal pre-cancer and cancer. Lucid also has a gastrointestinal health division that includes a different esophageal device for use in different indications.<blockquote>PAVmed 是 Lucid Diagnostics 的大股东，该公司负责开发据称是第一个也是唯一一个用于广泛早期检测食管癌前和癌症的商业工具。Lucid还有一个胃肠健康部门，包括一个不同的食管装置，用于不同的适应症。</blockquote> PAVmed's announcement revealed that Lucid has filed an S-1 registration statement with the Securities and Exchange Commission to go public. Lucid's ticker on the Nasdaq will be LUCD.<blockquote>PAVmed的公告透露，Lucid已经向美国证券交易委员会提交了S-1注册声明，准备上市。Lucid 在纳斯达克的股票代码为 LUCD。</blockquote> After the spinoff, PAVmed will be left with its remaining businesses, including its Veris Health digital sensor and patient monitoring subsidiary. Other divisions include minimally invasive devices treating carpal tunnel syndrome and various other innovative medical devices.<blockquote>分拆后，PAVmed 将保留其剩余业务，包括其 Veris Health 数字传感器和患者监测子公司。其他部门包括治疗腕管综合征的微创设备和各种其他创新医疗设备。</blockquote> PAVmed has climbed substantially this year, with the key appointment of a well-known executive in the genetic diagnostics field helping to bolster the value of Lucid's business in particular. Investors will have a chance to choose whether they see more value in Lucid or in PAVmed's other businesses after the IPO is complete.<blockquote>PAVmed 今年大幅攀升，基因诊断领域一位知名高管的关键任命尤其有助于提升 Lucid 的业务价值。IPO完成后，投资者将有机会选择是否在Lucid或PAVmed的其他业务中看到更多价值。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 2 Nasdaq Small Caps Just Got Big Boosts<blockquote>这两只纳斯达克小盘股刚刚获得大幅提振</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 2 Nasdaq Small Caps Just Got Big Boosts<blockquote>这两只纳斯达克小盘股刚刚获得大幅提振</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-09-24 17:43\n\n</h4>\n</header>\n<article>\n In a rising market, these companies looked especially impressive. Key Points<blockquote>在不断上涨的市场中，这些公司看起来尤其令人印象深刻。要点</blockquote> <ul> <li>The Nasdaq made big gains on Thursday.</li> <li>Veritone rose on an extended agreement with CBS News.</li> <li>PAVmed announced it had filed IPO paperwork for a major subsidiary.</li> </ul> Thursday was another great day for the stock market, although the&nbsp;Nasdaq Composite&nbsp;lagged behind some other major market benchmarks. Nevertheless, the Nasdaq managed to gain almost a full percentage point by 12:30 p.m. EDT, and it moved to within just a few percent of all-time record highs.<blockquote><ul><li>纳斯达克周四大幅上涨。</li><li>Veritone 因与 CBS 新闻的延长协议而上涨。</li><li>PAVmed 宣布已为一家主要子公司提交了 IPO 文件。</li></ul>周四对于股市来说又是一个伟大的一天，尽管纳斯达克复合材料落后于其他一些主要市场基准。尽管如此，到美国东部时间中午 12:30，纳斯达克还是成功上涨了几乎整整一个百分点，距离历史高点仅相差几个百分点。</blockquote> Small-cap stocksdon't always get as much attention as their larger counterparts, but they often have the best growth prospects. On Thursday morning, shares of&nbsp;<a href=\"https://laohu8.com/S/VERI\">Veritone Inc.</a> and&nbsp;<a href=\"https://laohu8.com/S/PAVM\">PAVmed</a> were among the top performers on the Nasdaq. Below, we'll look more closely at the news that moved these stocks, with an eye toward trying to figure out whether they'll be able to sustain their upward momentum.<blockquote>小盘股并不总是像大盘股那样受到关注，但它们通常具有最好的增长前景。周四上午，股价<a href=\"https://laohu8.com/S/VERI\">维里通公司。</a>和<a href=\"https://laohu8.com/S/PAVM\">帕夫梅德</a>是纳斯达克上表现最好的演员之一。下面，我们将更仔细地研究推动这些股票走势的消息，着眼于试图弄清楚它们是否能够维持上涨势头。</blockquote> A very valuable agreement for Veritone<blockquote>对于 Veritone 来说，这是一份非常有价值的协议</blockquote> Shares of Veritone were higher by more than 13% on Thursday morning. The provider of enterprise artificial-intelligence software announced a major deal that could play a key role in driving growth in the years to come.<blockquote>周四上午，Veritone 股价上涨超过 13%。这家企业人工智能软件提供商宣布了一项重大交易，该交易可能在未来几年推动增长方面发挥关键作用。</blockquote> Veritone has had a long relationship with the CBS News unit ofViacomCBS(NASDAQ:VIAC), spanning 11 years. It helps television producers, filmmakers, and other content creators take full advantage of news archive footage by using search and discovery functionality in its aiWARE platform. However, with the extended agreement announced today, Veritone and CBS News will boost access to the global creative community, allowing access not just to archival footage but also to breaking news content.<blockquote>Veritone 与 CBS 新闻部门有着长期的合作关系。维亚康姆哥伦比亚广播公司（纳斯达克股票代码：VIAC），跨越 11 年。它通过使用其aiWARE平台中的搜索和发现功能，帮助电视制片人、电影制作人和其他内容创作者充分利用新闻档案镜头。然而，随着今天宣布的扩展协议，Veritone和CBS News将增加对全球创意社区的访问，不仅允许访问档案镜头，还允许访问突发新闻内容。</blockquote> The exclusive international agreement will cover the next three years. With millions of hours in its library of content, CBS News and Veritone see the deal having a substantial influence on creators seeking to tie their content to current and past news events.<blockquote>独家国际协议将涵盖未来三年。CBS News和Veritone拥有数百万小时的内容，他们认为这笔交易将对寻求将内容与当前和过去的新闻事件联系起来的创作者产生重大影响。</blockquote> Veritone has made numerous effortsto foster its growth, including recent acquisitions to expand the functionality of its platform. Those efforts are now paying off in the CBS deal, and it'll be interesting to see how Veritone takes advantage of greater visibility as a result.<blockquote>Veritone 做出了许多努力来促进其发展，包括最近的收购以扩展其平台的功能。这些努力现在在哥伦比亚广播公司的交易中得到了回报，看看Veritone如何利用更大的知名度将会很有趣。</blockquote> Paving the way<blockquote>铺路</blockquote> Elsewhere, shares of PAVmed soared 16%. The maker of medical devices plans to do an initial public offering for one of its subsidiaries, potentially offering shareholders a chance to benefit directly from its prospects.<blockquote>其他方面，PAVmed 股价飙升 16%。这家医疗器械制造商计划为其子公司之一进行首次公开募股，这可能为股东提供直接从其前景中受益的机会。</blockquote> PAVmed is a majority owner of Lucid Diagnostics, which is responsible for what it says is the first and only commercial tools for widespread early detection of esophageal pre-cancer and cancer. Lucid also has a gastrointestinal health division that includes a different esophageal device for use in different indications.<blockquote>PAVmed 是 Lucid Diagnostics 的大股东，该公司负责开发据称是第一个也是唯一一个用于广泛早期检测食管癌前和癌症的商业工具。Lucid还有一个胃肠健康部门，包括一个不同的食管装置，用于不同的适应症。</blockquote> PAVmed's announcement revealed that Lucid has filed an S-1 registration statement with the Securities and Exchange Commission to go public. Lucid's ticker on the Nasdaq will be LUCD.<blockquote>PAVmed的公告透露，Lucid已经向美国证券交易委员会提交了S-1注册声明，准备上市。Lucid 在纳斯达克的股票代码为 LUCD。</blockquote> After the spinoff, PAVmed will be left with its remaining businesses, including its Veris Health digital sensor and patient monitoring subsidiary. Other divisions include minimally invasive devices treating carpal tunnel syndrome and various other innovative medical devices.<blockquote>分拆后，PAVmed 将保留其剩余业务，包括其 Veris Health 数字传感器和患者监测子公司。其他部门包括治疗腕管综合征的微创设备和各种其他创新医疗设备。</blockquote> PAVmed has climbed substantially this year, with the key appointment of a well-known executive in the genetic diagnostics field helping to bolster the value of Lucid's business in particular. Investors will have a chance to choose whether they see more value in Lucid or in PAVmed's other businesses after the IPO is complete.<blockquote>PAVmed 今年大幅攀升，基因诊断领域一位知名高管的关键任命尤其有助于提升 Lucid 的业务价值。IPO完成后，投资者将有机会选择是否在Lucid或PAVmed的其他业务中看到更多价值。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/09/23/these-2-nasdaq-small-caps-just-got-big-boosts/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VERI":"Veritone Inc.","PAVM":"PAVmed Inc."},"source_url":"https://www.fool.com/investing/2021/09/23/these-2-nasdaq-small-caps-just-got-big-boosts/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141045048","content_text":"In a rising market, these companies looked especially impressive.\n\nKey Points\n\nThe Nasdaq made big gains on Thursday.\nVeritone rose on an extended agreement with CBS News.\nPAVmed announced it had filed IPO paperwork for a major subsidiary.\n\nThursday was another great day for the stock market, although the Nasdaq Composite lagged behind some other major market benchmarks. Nevertheless, the Nasdaq managed to gain almost a full percentage point by 12:30 p.m. EDT, and it moved to within just a few percent of all-time record highs.\nSmall-cap stocksdon't always get as much attention as their larger counterparts, but they often have the best growth prospects. On Thursday morning, shares of Veritone Inc. and PAVmed were among the top performers on the Nasdaq. Below, we'll look more closely at the news that moved these stocks, with an eye toward trying to figure out whether they'll be able to sustain their upward momentum.\nA very valuable agreement for Veritone\nShares of Veritone were higher by more than 13% on Thursday morning. The provider of enterprise artificial-intelligence software announced a major deal that could play a key role in driving growth in the years to come.\nVeritone has had a long relationship with the CBS News unit ofViacomCBS(NASDAQ:VIAC), spanning 11 years. It helps television producers, filmmakers, and other content creators take full advantage of news archive footage by using search and discovery functionality in its aiWARE platform. However, with the extended agreement announced today, Veritone and CBS News will boost access to the global creative community, allowing access not just to archival footage but also to breaking news content.\nThe exclusive international agreement will cover the next three years. With millions of hours in its library of content, CBS News and Veritone see the deal having a substantial influence on creators seeking to tie their content to current and past news events.\nVeritone has made numerous effortsto foster its growth, including recent acquisitions to expand the functionality of its platform. Those efforts are now paying off in the CBS deal, and it'll be interesting to see how Veritone takes advantage of greater visibility as a result.\nPaving the way\nElsewhere, shares of PAVmed soared 16%. The maker of medical devices plans to do an initial public offering for one of its subsidiaries, potentially offering shareholders a chance to benefit directly from its prospects.\nPAVmed is a majority owner of Lucid Diagnostics, which is responsible for what it says is the first and only commercial tools for widespread early detection of esophageal pre-cancer and cancer. Lucid also has a gastrointestinal health division that includes a different esophageal device for use in different indications.\nPAVmed's announcement revealed that Lucid has filed an S-1 registration statement with the Securities and Exchange Commission to go public. Lucid's ticker on the Nasdaq will be LUCD.\nAfter the spinoff, PAVmed will be left with its remaining businesses, including its Veris Health digital sensor and patient monitoring subsidiary. Other divisions include minimally invasive devices treating carpal tunnel syndrome and various other innovative medical devices.\nPAVmed has climbed substantially this year, with the key appointment of a well-known executive in the genetic diagnostics field helping to bolster the value of Lucid's business in particular. Investors will have a chance to choose whether they see more value in Lucid or in PAVmed's other businesses after the IPO is complete.","news_type":1,"symbols_score_info":{"VERI":0.9,"PAVM":0.9}},"isVote":1,"tweetType":1,"viewCount":4283,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":7,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/861174576"}